![Samuel Broder](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Samuel Broder
Director/Board Member at
ORION BIOTECH OPPORTUNITIES CORP.
Profile
Samuel E.
Broder is currently serving as the Director at Catalytic IP, Inc., Geneos Therapeutics, Inc., Orion Biotech Opportunities Corp., National Academy of Sciences, and National Academy of Medicine (United States).
Previously, he held positions as the Director at Protein Design Labs, Inc., AbVitro LLC, and Panacea Pharmaceuticals, Inc. He also served as the Director at the National Cancer Institute from 1972 to 1995.
Additionally, he was the Director at PDL BioPharma, Inc. from 2005 to 2007, and a Non-Executive Director at ADC Therapeutics SA. Furthermore, he held the position of Director at Sapience Therapeutics, Inc. and served as the Chief Scientific Officer and SVP-Research & Dev at IVAX LLC from 1995 to 1998.
He was also the Senior Vice President & Head-Health Sector at Precigen, Inc. from 2014 to 2016, and the Chief Medical Officer & Vice President at Celera Corp.
from 1998 to 2010.
Dr. Broder obtained his undergraduate degree from the University of Michigan and his doctorate from the University of Michigan Medical School in 1970.
Samuel Broder active positions
| Companies | Position | Start |
|---|---|---|
| ORION BIOTECH OPPORTUNITIES CORP. | Director/Board Member | - |
Catalytic IP, Inc.
 Catalytic IP, Inc. Packaged SoftwareTechnology Services Develops digital research platform for life sciences companies that integrates research, data, analytics and collaboration tools in one secure place | Director/Board Member | - |
National Academy of Sciences
 National Academy of Sciences Miscellaneous Commercial ServicesCommercial Services Operates as a private, nongovernmental institution that advises on issues related to science and technology | Corporate Officer/Principal | 2010-06-21 |
National Academy of Medicine (United States)
 National Academy of Medicine (United States) Miscellaneous Commercial ServicesCommercial Services Operates as a professional membership organization | Corporate Officer/Principal | 2009-06-10 |
Geneos Therapeutics, Inc.
 Geneos Therapeutics, Inc. BiotechnologyHealth Technology Develops and commercializes neo-antigen based personalized cancer therapies | Director/Board Member | - |
Former positions of Samuel Broder
| Companies | Position | End |
|---|---|---|
| SENSEI BIOTHERAPEUTICS, INC. | Director/Board Member | 2024-02-04 |
| PRECIGEN, INC. | Chief Tech/Sci/R&D Officer | 2015-07-20 |
Celera Corp.
 Celera Corp. Medical/Nursing ServicesHealth Services Provides medical diagnostic services | Chief Tech/Sci/R&D Officer | 2009-12-31 |
| PDL BIOPHARMA, INC. | Director/Board Member | 2007-09-11 |
| ░░░░░░░ ░░░░░░ ░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
Training of Samuel Broder
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
82
1st degree connections
18
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 18 |
|---|---|
IVAX LLC
 IVAX LLC Pharmaceuticals: MajorHealth Technology Discovers, develops, manufactures & markets branded and generic pharmaceuticals | Health Technology |
Protein Design Labs, Inc.
 Protein Design Labs, Inc. Pharmaceuticals: MajorHealth Technology Develops humanized monoclonal antibodies | Health Technology |
Precigen, Inc.
 Precigen, Inc. BiotechnologyHealth Technology Operates as clinical-stage biopharmaceutical company | Health Technology |
Celera Corp.
Celera Corp. Medical/Nursing ServicesHealth Services Provides medical diagnostic services | Health Services |
AbVitro LLC
 AbVitro LLC BiotechnologyHealth Technology Provides an antibody discovery platform | Health Technology |
University of Michigan
 University of Michigan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
National Cancer Institute
 National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous Conducts research projects & awards grants for cancer research | Miscellaneous |
Panacea Pharmaceuticals, Inc.
 Panacea Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Manufactures and markets diagnostic products | Health Technology |
PDL BioPharma, Inc.
 PDL BioPharma, Inc. BiotechnologyHealth Technology Operates as a pharmaceutical company that manufactures and wholesales prescription medicine products | Health Technology |
National Academy of Sciences
National Academy of Sciences Miscellaneous Commercial ServicesCommercial Services Operates as a private, nongovernmental institution that advises on issues related to science and technology | Commercial Services |
National Academy of Medicine (United States)
National Academy of Medicine (United States) Miscellaneous Commercial ServicesCommercial Services Operates as a professional membership organization | Commercial Services |
ADC Therapeutics SA
 ADC Therapeutics SA Pharmaceuticals: MajorHealth Technology Develops proprietary antibody drug conjugates for the treatment of both solid and hematological cancers | Health Technology |
University of Michigan Medical School
 University of Michigan Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sapience Therapeutics, Inc.
 Sapience Therapeutics, Inc. BiotechnologyHealth Technology Provides biotechnology research services | Health Technology |
Catalytic IP, Inc.
Catalytic IP, Inc. Packaged SoftwareTechnology Services Develops digital research platform for life sciences companies that integrates research, data, analytics and collaboration tools in one secure place | Technology Services |
Geneos Therapeutics, Inc.
Geneos Therapeutics, Inc. BiotechnologyHealth Technology Develops and commercializes neo-antigen based personalized cancer therapies | Health Technology |
Sensei Biotherapeutics, Inc.
 Sensei Biotherapeutics, Inc. BiotechnologyHealth Technology Operates as clinical-stage biopharmaceutical company, which develops immunotherapies for cancers and infectious disease | Health Technology |
Orion Biotech Opportunities Corp.
 Orion Biotech Opportunities Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
- Stock Market
- Insiders
- Samuel Broder
